The role of microglia in neuropsychiatric disorders and suicide

Eur Arch Psychiatry Clin Neurosci. 2022 Sep;272(6):929-945. doi: 10.1007/s00406-021-01334-z. Epub 2021 Sep 30.

Abstract

This narrative review examines the possible role of microglial cells, first, in neuroinflammation and, second, in schizophrenia, depression, and suicide. Recent research on the interactions between microglia, astrocytes and neurons and their involvement in pathophysiological processes of neuropsychiatric disorders is presented. This review focuses on results from postmortem, positron emission tomography (PET) imaging studies, and animal models of schizophrenia and depression. Third, the effects of antipsychotic and antidepressant drug therapy, and of electroconvulsive therapy on microglial cells are explored and the upcoming development of therapeutic drugs targeting microglia is described. Finally, there is a discussion on the role of microglia in the evolutionary progression of human lineage. This view may contribute to a new understanding of neuropsychiatric disorders.

Keywords: Affective disorders; Bipolar disorder; Dorsal raphe nucleus; Evolution of human lineage; Major depressive disorder; Microglia; Schizophrenia; Serotonin; Suicide.

Publication types

  • Review

MeSH terms

  • Animals
  • Depressive Disorder, Major*
  • Humans
  • Microglia
  • Positron-Emission Tomography / methods
  • Schizophrenia* / therapy
  • Suicide* / psychology